Kaposi's Sarcoma

Childhood Survivors May be Predisposed to Cancer Later in Life

April 05, 2017

More than one-quarter of patients who survived childhood cancer had developed another cancer by the age of 45.

FDA Allows Use of E.U.-Approved Topical Drug Due to Shortage

By January 17, 2017

Due to a shortage of U.S.-approved Panretin gel (alitretinoin 0.1%; Eisai), the Food and Drug Administration (FDA) has announced they are allowing the sale of the E.U.-approved version of the gel, accompanied with a copy of the U.S.-approved prescribing information.

ANDA Accepted for Generic Doxil Injection

By October 31, 2016

Merrimack announced that the FDA has accepted for review the ANDA for generic Doxorubicin Hydrochloride (HCI) Liposome Injection.

Cancer Deaths Declining by 1.5% a Year in the U.S.

March 10, 2016

Overall rates of cancer and cancer mortality in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer.

Nearly 1 in 20 Cancer Patients Die Within Month of Surgery

October 16, 2014

In a study of more than 1.1 million cancer patients who had surgery, Harvard researchers found that almost 5% died within one month of their operation.

Targeted Cancer Drugs Among Successes, Says AACR

September 17, 2014

About 14.5 million U.S. cancer survivors are alive today, compared to just three million in 1971, with prevention and targeted therapies helping to reduce mortality.

Medical Practice Pleads Guilty to Unapproved Cancer Drugs

June 26, 2014

A medical practice in KY has pleaded guilty to federal charges regarding the purchasing and selling of unapproved and improperly labeled chemotherapy drugs.

Some Cancers Rates Associated with Income

May 29, 2014

The risk for certain types of cancer seems to be linked to poverty or wealth and socioeconomic status should be considered in cancer surveillance.

Shared Decision-Making Ups Satisfaction in Radiotherapy

April 24, 2014

For patients undergoing radiotherapy, shared decision-making and patient-perceived control in treatment decisions correlate with increased patient satisfaction.

Cancer Patients Need Anxiety, Depression Screening

April 22, 2014

It is important to recognize and treat anxiety or depression among cancer patients, according to panel recommendations.

Medicinal Mushrooms: Bioactive Compounds May Fight Disease

April 01, 2014

A significant number of modern prescription medications have been derived from mushrooms.

Elevated Morbidity Lasts for Childhood Cancer Survivors

March 25, 2014

By age 50 years, more than half of childhood cancer survivors have experienced a severe, disabling, life-threatening, or fatal health condition.

Do Cancer Patients with Diabetes Have Greater Mortality Rates?

March 19, 2014

The comorbid condition of diabetes may contribute to increased mortality in patients with cancer.

Many Oncologists Not Satisfied With Work-Life Balance

March 13, 2014

About one-third of U.S. oncologists report being satisfied with work-life balance (WLB), which is lower than for other medical specialties.

Demand for Quality Cancer Care Increasing

March 11, 2014

The demand for quality cancer care is increasing, but millions of patients lack access to care.

Reducing Cancer Care Cost Sans Patient Risk

March 10, 2014

Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.

Palliative Chemo for Terminal Cancer Linked to Death in ICU

March 07, 2014

Terminally ill patients with cancer who receive chemotherapy at the end of life are at increased risk of dying in an ICU and receiving CPR and/or mechanical ventilation.

USPSTF: Evidence Lacking for Vitamin Prevention of CVD, CA

February 25, 2014

The USPSTF has found that insufficient evidence to evaluate the benefits and harms of multivitamins and most single- or paired-nutrient supplements for the prevention of cardiovascular disease and cancer.

Patients Are 'Myth'-Informed About Their Risk of Cancer

February 04, 2014

Fewer than half of Americans are aware that body weight and physical activity affect cancer risk.

First- and Second-Generation Family Hx Adequate in Oncology

February 04, 2014

Recommendations relating to the key elements of minimum adequate cancer family history are detailed, although they are often incompletely implemented.

Exercise Important for Men After Cancer Diagnosis

January 28, 2014

Men who are physically active after a cancer diagnosis have significantly improved survival.

Has the 'War on Cancer' Made Progress?

January 24, 2014

More people are being diagnosed with and dying from cancer, but this is largely the result of declines in mortality from other causes.

FDA: Liposomal Doxorubicin HCl Supply Update

October 08, 2013

Sun Pharma announced that it has sufficient supplies of Doxorubicin HCl Liposome Injection to cover the U.S. market as Janssen's Doxil ends production.

More Than 1.6 Million Americans Expected to Get Cancer in 2013

September 17, 2013

Although significant progress has been made in treating cancer, >1.6 million Americans are projected to receive a cancer diagnosis in 2013.

Novel Chemotherapies More Often Used On- Than Off-Label

February 26, 2013

In contemporary practice, medical oncologists use novel anticancer agents on-label more often than off-label.

Fewer Medicare Patients Dying in Hospital Setting

February 06, 2013

Fewer Medicare beneficiaries are dying in the setting of acute care hospitals, but health care transitions and intensive care unit (ICU) utilization are increasing in the last month of life.

FDA Approves Generic Doxil Injection

February 04, 2013

The FDA announced that it has approved Doxorubicin HCl Liposome Injection, the first generic version of Janssen Biotech's Doxil.

Moxifloxacin Monotherapy Equivalent to Antibiotic Combo

January 30, 2013

Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who are at low risk of complications.